Protalix BioTherapeutics Inc. (DE) (PLX)
NYSE: PLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.66 -1.85%
PLX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $218.35M
- P/E (TTM)
- 11.78
- Forward P/E
- 4.37
- EPS (TTM)
- $0.23
- Dividend yield
- None
- 52-week range
- 1.60 – 3.19
- Day range
- 2.70 – 2.76
- Volume / Avg
- 794.48K / 729.36K
- Beta
- —
- Shares outstanding
- 80.57M
52-week range
PLX stock today
Protalix BioTherapeutics (DE) (PLX) closed at $2.71 on Oct 7, down 0.73% (-$0.02), versus the S&P 500's 0.22% decline. At this level, PLX sits in the middle of its 52-week range of $1.60 to $3.19: 15.0% below the high, set on Feb 23, 2026 and 69.4% above the low. PLX is up 50.6% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 8.4%.
Protalix BioTherapeutics (DE) trades at 11.8x its trailing twelve-month earnings per share of $0.23. Its forward P/E of 4.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Protalix BioTherapeutics (DE)
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Protalix BioTherapeutics (DE) peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IVVDInvivyd Inc. | 0.7286 | -9.65% | $214.76M | vs PLX |
| ALECAlector Inc. | 1.92 | +6.08% | $214.38M | vs PLX |
| IPSCCentury Therapeutics Inc. | 1.28 | -3.03% | $231.78M | vs PLX |
| CGENCompugen Ltd. | 2.15 | -3.15% | $203.66M | vs PLX |
| LCTXLineage Cell Therapeutics Inc. | 0.9476 | +1.03% | $239.66M | vs PLX |
| STROSutro Biopharma Inc. | 14.66 | +1.45% | $243.08M | vs PLX |
| CMPXCompass Therapeutics Inc. | 1.02 | +2.19% | $183.69M | vs PLX |
| FATEFate Therapeutics Inc. | 2.15 | -6.11% | $257.61M | vs PLX |
Indexes, lists and sector
Protalix BioTherapeutics (DE) stock FAQ
What is Protalix BioTherapeutics (DE)'s stock price today?
PLX last traded at $2.71 as of Oct 7, 4:00 PM EDT, down 0.73% on the day. Prices are delayed at least 15 minutes.
Does Protalix BioTherapeutics (DE) pay a dividend?
No. Protalix BioTherapeutics (DE) does not currently pay a regular cash dividend.
What is PLX's P/E ratio?
PLX trades at a trailing P/E ratio of 11.78 and a forward P/E of 4.37.
Has PLX ever split its stock?
Yes. The most recent PLX stock split was a 1-for-10 split on Dec 20, 2019, one of 2 splits on record.
What is the PLX 52-week high?
The 52-week high for PLX is $3.19 and the 52-week low is $1.60. The stock is currently 15.0% below its high.